Skip to main content
. 2021 May 12;151(8):2153–2160. doi: 10.1093/jn/nxab119

TABLE 1.

Characteristics of the 100 study participants enrolled in this randomized controlled trial1

Placebo Citicoline
(n = 51) (n = 49) P
Age,2 y 65.5 ± 1.13 63.2 ± 1.12 0.53
Gender,3 n (%)
 Male 16 (31.4) 19 (38.8)
 Female 35 (68.6) 30 (61.2) 0.16
Race,3n (%) 0.17
 White 47 (92.2) 41 (83.7)
 Black/African American 3 (5.88) 7 (14.3)
 American Indian or Alaskan Native 0 (0.00) 1 (2.04)
 Asian 0 (0.00) 0 (0.00)
 Native Hawaiian or other Pacific Islander 1 (1.92) 0 (0.00)
Ethnicity,3n (%) 1.00
 Not Hispanic/Latino 49 (96.1) 48 (98.0)
 Hispanic/Latino 2 (3.92) 1 (2.04)
BMI,2 kg/m2 29.6 ± 0.96 30.7 ± 0.91 0.35
Systolic BP,2 mm Hg 127 ± 2.06 130 ± 1.83 0.25
Diastolic BP,2 mm Hg 74.4 ± 1.64 76.1 ± 1.38 0.44
MMSE2 27.6 ± 0.22 27.8 ± 0.21 0.50
KBIT-22 101 ± 1.45 98.9 ± 1.26 0.30
Geriatric Depression Scale2 0.784 ± 0.144 0.796 ± 0.124 0.95
Spatial Span score (at screening)2 3.71 ± 0.08 3.80 ± 0.06 0.35
Hours of sleep (at Week 0),2 h 7.32 ± 0.12 7.20 ± 0.11 0.47
1

Values are means ± SEMs or frequency (%). Differences between placebo and citicoline groups for all characteristics were analyzed using independent t-test for continuous variables and Fisher's exact test for categorical variables. BP, blood pressure; kg, kilogram; KBIT-2, Kaufman Brief Intelligence Test, Second Edition; m, meter; mm Hg, millimeter mercury; MMSE, Mini-Mental State Examination.

2

Independent t-test.

3

Fisher's exact test.